PDCD1 and colorectal carcinoma: Furthermore, in a model of colorectal carcinoma (CRC), administration of AT-SPM regulated macrophage trafficking by stimulating the clearance of apoptotic cells and reduced the expression of the immunosuppressive receptor PD-1 in both macrophages and CD8+ T cells [64].